Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review.  Leiber KK, Parker RW.  Cureus. 2025 Mar 24;17(3):e81086. doi: 10.7759/cureus.81086. PMID: 40271304; PMCID: PMC12017383. https://pmc.ncbi.nlm.nih.gov/articles/PMC12…

Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial.  Magane KM, Dukes KA, Fielman S, et al.  JAMA Intern Med. Published online April 21, 202…

Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database.  Zeng Y, Chen Z, Luo Y, Luo J, Shi L, Zhou X.  Expert Opin Drug Saf. 2025 Feb 2:1-8. doi: 10.1080/14740338…

Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients.  Qu W, Wang X, Dong C, Zhang T, Yin S, Sun Z, Wang S, Guo A, Hao W. …

Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals.  Solli KK, Benth JŠ, Digranes LCW, Holtan L, Kunoe N, Tanum L.  Contemp Clin Trials. 2025 Feb…

Delirium secondary to inadvertent administration of naltrexone in patient with opioid dependence syndrome: a case report.  Aggarwal K, Ranjan R, Mallik S, Salian HH, Shekhar S.  East Asian Arch Psychiatry. 2024 Sep;34(3):87-88. doi: 10.1…